metabolic
Efpeglenatide
Ultra-long-acting GLP-1 agonist
0 vendors tracked0 live pricesLast crawl: 2026-04-27 01:38 UTC
About
An ultra-long-acting exenatide analog engineered for monthly dosing. Phase 3 trials completed for type-2 diabetes.
Also known as: LongGLP
Related peptides